Literature DB >> 17164976

Schwann cells in neuroblastoma express erythropoietin.

Domenico Ribatti, Andrea Marzullo, Vito Longo, Luigi Poliani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17164976     DOI： 10.1007/s11060-006-9289-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.506


× No keyword cloud information.
  17 in total

1.  The International Neuroblastoma Pathology Classification (the Shimada system).

Authors:  H Shimada; I M Ambros; L P Dehner; J Hata; V V Joshi; B Roald; D O Stram; R B Gerbing; J N Lukens; K K Matthay; R P Castleberry
Journal:  Cancer       Date:  1999-07-15       Impact factor: 6.860

2.  Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo.

Authors:  D Ribatti; M Presta; A Vacca; R Ria; R Giuliani; P Dell'Era; B Nico; L Roncali; F Dammacco
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

3.  Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury.

Authors:  W M Campana; R R Myers
Journal:  FASEB J       Date:  2001-08       Impact factor: 5.191

4.  In vivo evidence that erythropoietin protects neurons from ischemic damage.

Authors:  M Sakanaka; T C Wen; S Matsuda; S Masuda; E Morishita; M Nagao; R Sasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

5.  Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo.

Authors:  Y Konishi; D H Chui; H Hirose; T Kunishita; T Tabira
Journal:  Brain Res       Date:  1993-04-23       Impact factor: 3.252

6.  Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival.

Authors:  Sandeep Batra; Natalya Perelman; Lori R Luck; Hiroyuki Shimada; Punam Malik
Journal:  Lab Invest       Date:  2003-10       Impact factor: 5.662

7.  Identification of a neurotrophic sequence in erythropoietin.

Authors:  W M Campana; R Misasi; J S O'Brien
Journal:  Int J Mol Med       Date:  1998-01       Impact factor: 4.101

8.  Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity.

Authors:  S E Crawford; V Stellmach; M Ranalli; X Huang; L Huang; O Volpert; G H De Vries; L P Abramson; N Bouck
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

9.  Erythropoietin receptor signalling is required for normal brain development.

Authors:  Xiaobing Yu; John J Shacka; Jeffrey B Eells; Carlos Suarez-Quian; Ronald M Przygodzki; Bojana Beleslin-Cokic; Chyuan-Sheng Lin; Vera M Nikodem; Barbara Hempstead; Kathleen C Flanders; Frank Costantini; Constance Tom Noguchi
Journal:  Development       Date:  2002-01       Impact factor: 6.868

10.  Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis.

Authors:  M E Hardee; J P Kirkpatrick; S Shan; S A Snyder; Z Vujaskovic; Z N Rabbani; M W Dewhirst; K L Blackwell
Journal:  Br J Cancer       Date:  2005-12-12       Impact factor: 7.640
View more
  3 in total

1.  HMGB1-induced autophagy in Schwann cells promotes neuroblastoma proliferation.

Authors:  Yongsheng Liu; Laijun Song
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 2.  Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.

Authors:  Julia Bohlius; Kurt Schmidlin; Corinne Brillant; Guido Schwarzer; Sven Trelle; Jerome Seidenfeld; Marcel Zwahlen; Mike J Clarke; Olaf Weingart; Sabine Kluge; Margaret Piper; Maryann Napoli; Dirk Rades; David Steensma; Benjamin Djulbegovic; Martin F Fey; Isabelle Ray-Coquard; Volker Moebus; Gillian Thomas; Michael Untch; Martin Schumacher; Matthias Egger; Andreas Engert
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

3.  Prognostic significance of erythropoietin in pancreatic adenocarcinoma.

Authors:  Thilo Welsch; Stefanie Zschäbitz; Verena Becker; Thomas Giese; Frank Bergmann; Ulf Hinz; Shereen Keleg; Anette Heller; Bence Sipos; Ursula Klingmüller; Markus W Büchler; Jens Werner; Nathalia A Giese
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.